As Caeregen’s CDMO partner for CTR-107, Wacker Biotech will produce drug substance at its site in Halle, Germany, and complete clinical trial drug product production at its site in Amsterdam, the Netherlands
GL0034 is a novel, investigational glucagon-like peptide 1 receptor agonist (GLP-1RA) being studied for the treatment of type 2 diabetes and obesity
Carbogen Amcis Manchester won the industry award in recognition of its efficiency improvement program implemented in response to increased demand for its products
Dignitaries and delegates commend India’s leadership in Global South during G20 India Presidency
The partnership aims to prioritize the diagnosis and treatment of these diseases while working to reducing their long-term prevalence
Sajjan India Limited is looking for expansion, both organically and through acquisitions, to achieve the planned growth
Columvi is part of Roche's industry-leading portfolio of T-cell engaging bispecific antibodies in non-Hodgkin lymphoma, which also includes the recently approved Lunsumio to treat follicular lymphoma
Cullgen will have the option during the initial stages of clinical development to participate equally in the costs, profits and losses
Convergent action on AMR identified as an important area of intervention
Subscribe To Our Newsletter & Stay Updated
